NexImmune Inc (OTCPK:NEXI)
$ 0.25 0 (0%) Market Cap: 350,000.00 Enterprise Value: -4.19 Mil PE Ratio: 0 PB Ratio: 0.38 GF Score: 34/100

NexImmune joins BioTalk to discuss his career in the BioHealth Capital Region Transcript

Oct 26, 2020 / NTS GMT
Unidentified Participant

You are listening to BioTalk with Rich Bendis, the only podcast focused on the BioHealth Capital Region. Each episode, we'll talk to leaders in the industry to break down the biggest topics happening today in BioHealth.

Rich Bendis
BioHealth Innovation, Inc. - President & CEO

Hi, this is Rich Bendis. I'm your host of BioTalk. And we're talking to leaders in the BioHealth Capital Region. And today, I have someone I haven't talked to for a few years. They happen to be the first Chairman of the Board for BioHealth Innovation when we were created, and we partnered with MedImmune back at that time as one of our anchor partners. And I have the pleasure of speaking to my former Chairperson, Scott Carmer, who's now the CEO for several years of NexImmune.

Scott, welcome to BioTalk.

Scott Carmer;Rich Bendis
NexImmune Inc. - CEO

Well, that seems so strange. It sounds strange to hear you repeat that. But it's wonderful to be reconnected, Rich. Really looking forward to the discussion.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot